Abramson Cancer Center

Abramson Cancer Center melanoma researchers and clinicians have led the way nationally, for decades, in understanding the causes of melanoma/pigmented lesions, and in finding more effective treatments.

Today there's more hope than ever for those who face melanoma. Our team has worked together for years caring for those with melanoma. By putting our experience to work, we offer the best possible treatment outcomes.

If diagnosed with melanoma, have a change in a mole, or you are at increased risk for melanoma, it's important to have the best team of experts.

At Penn's Melanoma/ Pigmented Lesion Program there are individuals nationally recognized for their expertise. They can provide the information, care and support to help each step of the way.

Penn’s Pigmented Lesion Group

We are committed not only to identifying and treating melanoma as soon as possible, but also preventing it.

Penn was one of the first in the country to establish a Pigmented Lesion Group (PLG) to provide information, evaluation, and genetic counseling for those at increased risk for melanoma.

Our group set the standard by creating a national model for melanoma screening.

Our outstanding Melanoma Research Program is recognized and funded by the National Cancer Institute, ensuring that the latest discovery is translated to better patient care immediately. Everyday our scientists conduct research that leads us closer to learning the causes of melanoma and to developing new treatments.

For decades, we have led the way nationally in understanding the causes of melanoma/pigmented lesions, identifying the factors that contribute to increased risk, and developing new and more effective forms of treatment.

The knowledge gained through our research allows us to better care for those with or at risk for melanoma.

To learn about what sets us apart, visit:

• The Penn Difference
• Premier Research Program
• Team Approach/Multidisciplinary Care
• About our Physicians/Staff